Annual CFI
-$404.08 M
-$543.96 M-388.86%
December 31, 2024
Summary
- As of March 13, 2025, KYMR annual cash flow from investing activities is -$404.08 million, with the most recent change of -$543.96 million (-388.86%) on December 31, 2024.
- During the last 3 years, KYMR annual CFI has fallen by -$304.24 million (-304.74%).
- KYMR annual CFI is now -388.86% below its all-time high of $139.89 million, reached on December 31, 2023.
Performance
KYMR Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$68.57 M
+$226.25 M+143.49%
December 31, 2024
Summary
- As of March 13, 2025, KYMR quarterly cash flow from investing activities is $68.57 million, with the most recent change of +$226.25 million (+143.49%) on December 31, 2024.
- Over the past year, KYMR quarterly CFI has increased by +$49.62 million (+261.80%).
- KYMR quarterly CFI is now -16.18% below its all-time high of $81.80 million, reached on June 30, 2022.
Performance
KYMR Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$404.08 M
+$49.62 M+10.94%
December 31, 2024
Summary
- As of March 13, 2025, KYMR TTM cash flow from investing activities is -$404.08 million, with the most recent change of +$49.62 million (+10.94%) on December 31, 2024.
- Over the past year, KYMR TTM CFI has dropped by -$543.96 million (-388.86%).
- KYMR TTM CFI is now -388.86% below its all-time high of $139.89 million, reached on December 31, 2023.
Performance
KYMR TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
KYMR Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -388.9% | +261.8% | -388.9% |
| 3 y3 years | -304.7% | +261.8% | -388.9% |
| 5 y5 years | -2351.0% | +261.8% | -388.9% |
KYMR Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -388.9% | at low | -16.2% | +120.7% | -388.9% | +10.9% |
| 5 y | 5-year | -388.9% | +4.4% | -16.2% | +120.5% | -388.9% | +10.9% |
| alltime | all time | -388.9% | +4.4% | -16.2% | +120.5% | -388.9% | +10.9% |
Kymera Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$404.08 M(-388.9%) | $68.57 M(-143.5%) | -$404.08 M(-10.9%) |
| Sep 2024 | - | -$157.68 M(-1108.1%) | -$453.69 M(+92.6%) |
| Jun 2024 | - | $15.64 M(-104.7%) | -$235.50 M(+9.4%) |
| Mar 2024 | - | -$330.61 M(-1844.4%) | -$215.31 M(-253.9%) |
| Dec 2023 | $139.89 M(+581.7%) | $18.95 M(-68.7%) | $139.89 M(+96.3%) |
| Sep 2023 | - | $60.51 M(+68.8%) | $71.27 M(-366.7%) |
| Jun 2023 | - | $35.84 M(+45.8%) | -$26.72 M(-238.9%) |
| Mar 2023 | - | $24.58 M(-149.5%) | $19.24 M(-6.2%) |
| Dec 2022 | $20.52 M | -$49.67 M(+32.5%) | $20.52 M(+847.3%) |
| Sep 2022 | - | -$37.48 M(-145.8%) | $2.17 M(-102.2%) |
| Jun 2022 | - | $81.80 M(+216.3%) | -$97.22 M(-17.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $25.86 M(-138.0%) | -$118.30 M(+18.5%) |
| Dec 2021 | -$99.83 M(-76.4%) | -$68.02 M(-50.3%) | -$99.83 M(+178.8%) |
| Sep 2021 | - | -$136.86 M(-325.4%) | -$35.81 M(-84.7%) |
| Jun 2021 | - | $60.72 M(+37.0%) | -$233.26 M(-31.6%) |
| Mar 2021 | - | $44.32 M(-1210.9%) | -$340.86 M(-19.3%) |
| Dec 2020 | -$422.59 M(+2463.3%) | -$3.99 M(-98.8%) | -$422.59 M(+1.0%) |
| Sep 2020 | - | -$334.32 M(+613.2%) | -$418.60 M(+396.7%) |
| Jun 2020 | - | -$46.87 M(+25.3%) | -$84.28 M(+125.3%) |
| Mar 2020 | - | -$37.40 M | -$37.40 M |
| Dec 2019 | -$16.49 M(+1115.8%) | - | - |
| Dec 2018 | -$1.36 M | - | - |
FAQ
- What is Kymera Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Kymera Therapeutics?
- What is Kymera Therapeutics annual CFI year-on-year change?
- What is Kymera Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Kymera Therapeutics?
- What is Kymera Therapeutics quarterly CFI year-on-year change?
- What is Kymera Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Kymera Therapeutics?
- What is Kymera Therapeutics TTM CFI year-on-year change?
What is Kymera Therapeutics annual cash flow from investing activities?
The current annual CFI of KYMR is -$404.08 M
What is the all time high annual CFI for Kymera Therapeutics?
Kymera Therapeutics all-time high annual cash flow from investing activities is $139.89 M
What is Kymera Therapeutics annual CFI year-on-year change?
Over the past year, KYMR annual cash flow from investing activities has changed by -$543.96 M (-388.86%)
What is Kymera Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of KYMR is $68.57 M
What is the all time high quarterly CFI for Kymera Therapeutics?
Kymera Therapeutics all-time high quarterly cash flow from investing activities is $81.80 M
What is Kymera Therapeutics quarterly CFI year-on-year change?
Over the past year, KYMR quarterly cash flow from investing activities has changed by +$49.62 M (+261.80%)
What is Kymera Therapeutics TTM cash flow from investing activities?
The current TTM CFI of KYMR is -$404.08 M
What is the all time high TTM CFI for Kymera Therapeutics?
Kymera Therapeutics all-time high TTM cash flow from investing activities is $139.89 M
What is Kymera Therapeutics TTM CFI year-on-year change?
Over the past year, KYMR TTM cash flow from investing activities has changed by -$543.96 M (-388.86%)